BMC Urology

unofficial impact factor 1.43

Section Editors

  • Steven Brandes, Washington university
  • John Gearhart, Johns Hopkins Children's Center
  • Debra E Irwin, University of North Carolina at Chapel Hill
  • Ercan Kocakoc, Bezmialem Vakif University
  • Salvatore Micali, University of Modena and Reggio Emilia
  • Charles J Rosser, University of Florida
  • Mostafa Taymour, University of Cairo

Executive Editor

  • Hayley Henderson, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: Yohn et al. BMC Urology 2011, 11:19

    p21 upregulation in urothelial carcinoma cells

    The phosphatidylinositol 3'-kinase (PI3K) growth factor signaling pathway upregulates p21 by suppressing glycogen synthase kinase-3 beta activity and activating mTOR in both cultured human urothelial carcinoma cells and mouse urothelial cells in vivo.

    BMC Urology 2011, 11:19

RSS

Comments

View more comments

Scope



BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Quote

Sally Blower
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA

Email alerts

Receive periodic news and updates relating to BioMed Central.

Indexed by

  • CAS
  • Embase
  • MEDLINE
  • PubMed
  • Scopus

View all

ISSN: 1471-2490